Satellos Bioscience Inc. (TSX:MSCL)
Canada · Delayed Price · Currency is CAD 9.50
-0.40 (-4.04%)
Oct 14, 2026, 3:56 PM EST
Satellos Bioscience Market Cap
Satellos Bioscience has a market cap or net worth of CAD 201.56 million as of October 14, 2026. It is the 22,986th most valuable company in the world and the 593rd biggest in Canada. Its market cap has increased by 36.12% in one year.
Market Cap
201.56M
Enterprise Value
113.74M
Revenue
n/a
Global Rank
Country Rank
#593 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since August 19, 2021, Satellos Bioscience's market cap has increased from 58.83M to 201.56M, an increase of 242.60%. That is a compound annual growth rate of 26.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 201.56M | 64.62% |
| Dec 31, 2025 | 122.43M | -11.04% |
| Dec 31, 2024 | 137.63M | 183.77% |
| Dec 29, 2023 | 48.50M | 427.44% |
| Dec 30, 2022 | 9.20M | -72.13% |
| Dec 31, 2021 | 33.00M | -43.91% |
| Aug 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 700.35M |
| Eupraxia Pharmaceuticals | 616.89M |
| Eastwood Bio-Medical Canada | 119.17M |
| Helix BioPharma | 70.27M |
| NurExone Biologic | 55.91M |
| ME Therapeutics Holdings | 48.62M |
| BriaCell Therapeutics | 45.67M |
| MedMira | 45.61M |